CureMetrix is a global leader in Artificial Intelligence for medical imaging, committed to advancing technology that improves disease detection and cancer survival rates across the globe. Its mission is to help save lives and support improved clinical and financial outcomes, delivering technology that radiologists, healthcare systems, and patients can rely on with confidence. cmTriage® is FDA-cleared for commercial use in the U.S. cmTriage® and cmAssist® are ANVISA cleared in Brazil. cmAssist®, cmAngio™, and cmDensity™ are in development and are not yet available for commercial use in the U.S.